We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$64.7B
AUM Growth
+$5.24B
Cap. Flow
+$2.36B
Cap. Flow %
3.65%
Top 10 Hldgs %
20.54%
Holding
3,821
New
235
Increased
1,962
Reduced
1,317
Closed
186

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$40.1M
2
T icon
AT&T
T
+$28M
3
FTXO icon
First Trust Nasdaq Bank ETF
FTXO
+$24.3M
4
TTE icon
TotalEnergies
TTE
+$23.7M
5
WMT icon
Walmart Inc
WMT
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 10.68%
2 Financials 9.21%
3 Healthcare 8.48%
4 Industrials 6.92%
5 Consumer Discretionary 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOW icon
2126
CALL
Lowe's Companies
LOW
$121B
$1.19M ﹤0.01%
63,300
GER
2127
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
$1.19M ﹤0.01%
20,418
+951
+5% +$56.2K
PCEF icon
2128
Invesco CEF Income Composite ETF
PCEF
$822M
$1.18M ﹤0.01%
51,897
+1,585
+3% +$36.3K
CUK
2129
DELISTED
Carnival PLC
CUK
$1.18M ﹤0.01%
18,755
-9,037
-33% -$545K
CARO
2130
DELISTED
Carolina Financial Corp.
CARO
$1.18M ﹤0.01%
31,310
-186
-0.6% -$7.7K
AC
2131
DELISTED
Associated Capital Group
AC
$1.18M ﹤0.01%
27,854
+4,915
+21% +$188K
NGL icon
2132
NGL Energy Partners
NGL
$2.16B
$1.18M ﹤0.01%
101,546
+17,457
+21% +$212K
RVTY icon
2133
Revvity
RVTY
$13.1B
$1.18M ﹤0.01%
12,108
+6,043
+100% +$519K
IDTI
2134
DELISTED
Integrated Device Technology I
IDTI
$1.18M ﹤0.01%
25,051
-37,050
-60% -$1.43M
ETO
2135
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$528M
$1.18M ﹤0.01%
46,469
-2,121
-4% -$53.5K
EVA
2136
DELISTED
Enviva Inc.
EVA
$1.18M ﹤0.01%
36,987
+3,982
+12% +$122K
DNP icon
2137
DNP Select Income Fund
DNP
$4.11B
$1.17M ﹤0.01%
105,675
+5,433
+5% +$59.8K
GATX icon
2138
GATX Corp
GATX
$6.31B
$1.17M ﹤0.01%
13,488
+320
+2% +$26.5K
FHI icon
2139
Federated Hermes
FHI
$4.73B
$1.16M ﹤0.01%
48,243
+35,389
+275% +$832K
KLXI
2140
DELISTED
KLX Inc.
KLXI
$1.16M ﹤0.01%
18,462
-4,578
-20% -$282K
OMER icon
2141
Omeros
OMER
$1.29B
$1.16M ﹤0.01%
47,300
+500
+1% +$11.2K
SVC
2142
Service Properties Trust
SVC
$1.06B
$1.15M ﹤0.01%
7,995
-268
-3% -$38.4K
KTOS icon
2143
Kratos Defense & Security Solutions
KTOS
$11.9B
$1.15M ﹤0.01%
+77,791
New +$1.03M
DGS icon
2144
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.77B
$1.15M ﹤0.01%
25,166
-1,507
-6% -$70.8K
ACP
2145
abrdn Income Credit Strategies Fund
ACP
$644M
$1.15M ﹤0.01%
83,259
-613
-0.7% -$8.36K
SLYV icon
2146
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.11B
$1.15M ﹤0.01%
16,801
+5,277
+46% +$365K
NXG
2147
NXG NextGen Infrastructure Income Fund
NXG
$355M
$1.14M ﹤0.01%
14,848
-762
-5% -$57.6K
JPSE icon
2148
JPMorgan Diversified Return US Small Cap Equity ETF
JPSE
$608M
$1.14M ﹤0.01%
35,048
+323
+0.9% +$10.5K
ETX
2149
Eaton Vance Municipal Income 2028 Term Trust
ETX
$200M
$1.14M ﹤0.01%
58,377
+7,080
+14% +$140K
TJX icon
2150
CALL
TJX Companies
TJX
$169B
$1.14M ﹤0.01%
89,200
-60,000
-40% -$3.08M

Similar funds

Raymond James & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Raymond James & Associates held 3,821 positions worth $64.7B, up 8.8% from $59.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates deployed $2.36B of net new capital in Q3 2018, opening 235 new positions and adding to 1,962 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Sanofi, an estimated $40.1M trimmed.

  • Raymond James & Associates's largest Q3 2018 buy was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2018, an estimated $155M increase.
  • Raymond James & Associates's biggest Q3 2018 reduction was Sanofi, cutting an estimated $40.1M.
  • Raymond James & Associates fully exited Abaxis Inc in Q3 2018, selling an estimated $10.5M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $64.7B portfolio in Q3 2018.
  • Raymond James & Associates opened 235 new positions and closed 186 in Q3 2018.
  • Raymond James & Associates's portfolio value rose 8.8% quarter-over-quarter to $64.7B.

Based on Raymond James & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.